Protalix BioTherapeutics
PLX
#7937
Rank
NZ$0.38 B
Marketcap
$4.79
Share price
-3.06%
Change (1 day)
136.92%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): NZ$9.1 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are NZ$53.39 Million. a decrease over its 2023 earnings that were of NZ$19.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 NZ$8.76 M-55.62%
2023 NZ$19.74 M-199.05%
2022 -NZ$19.94 Million-40.38%
2021 -NZ$33.44 Million-732.31%
2020 NZ$5.28 M-130.53%
2019 -NZ$17.32 Million189.85%
2018 -NZ$5.98 Million-95.29%
2017 -NZ$0.13 Billion308.12%
2016 -NZ$31.09 Million-32.37%
2015 -NZ$45.97 Million10.11%
2014 -NZ$41.75 Million-7.59%
2013 -NZ$45.18 Million
2011 -NZ$52.32 Million-19.39%
2010 -NZ$64.9 Million20.87%
2009 -NZ$53.7 Million32.26%
2008 -NZ$40.6 Million-5.46%
2007 -NZ$42.94 Million
2004 -NZ$0.28 Million12.35%
2003 -NZ$0.25 Million-11.1%
2002 -NZ$0.28 Million-57.03%
2001 -NZ$0.65 Million1.03%
2000 -NZ$0.65 Million-53.22%
1999 -NZ$1.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$48.3 Million-651.30%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.86 B 9,740.87%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$18.66 B 212,955.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.48 Billion-5,506.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel